Works matching IS 13524585 AND DT 2018 AND VI 24 AND IP 5


Results: 19
    1
    2
    3
    4
    5
    6

    Designing an epigenomic study.

    Published in:
    Multiple Sclerosis Journal, 2018, v. 24, n. 5, p. 604, doi. 10.1177/1352458517750770
    By:
    • Ma, Yiyi;
    • De Jager, Philip L.
    Publication type:
    Article
    7

    Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus seroconversion rates under natalizumab treatment and differences between technical and biological sero-converters

    Published in:
    Multiple Sclerosis Journal, 2018, v. 24, n. 5, p. 563, doi. 10.1177/1352458517728814
    By:
    • Schwab, Nicholas;
    • Schneider-Hohendorf, Tilman;
    • Hoyt, Tammy;
    • Gross, Catharina C.;
    • Meuth, Sven G.;
    • Klotz, Luisa;
    • Foley, John F.;
    • Wiendl, Heinz
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.

    Published in:
    Multiple Sclerosis Journal, 2018, v. 24, n. 5, p. 642, doi. 10.1177/1352458517703800
    By:
    • Signori, Alessio;
    • Izquierdo, Guillermo;
    • Lugaresi, Alessandra;
    • Hupperts, Raymond;
    • Grand'Maison, Francois;
    • Sola, Patrizia;
    • Horakova, Dana;
    • Havrdova, Eva;
    • Prat, Alexandre;
    • Girard, Marc;
    • Duquette, Pierre;
    • Boz, Cavit;
    • Grammond, Pierre;
    • Terzi, Murat;
    • Singhal, Bhim;
    • Alroughani, Raed;
    • Petersen, Thor;
    • Ramo, Cristina;
    • Oreja-Guevara, Celia;
    • Spitaleri, Daniele
    Publication type:
    Article
    16
    17
    18
    19